AU1889588A - Use of an agent with a high affinity for tumours - Google Patents

Use of an agent with a high affinity for tumours

Info

Publication number
AU1889588A
AU1889588A AU18895/88A AU1889588A AU1889588A AU 1889588 A AU1889588 A AU 1889588A AU 18895/88 A AU18895/88 A AU 18895/88A AU 1889588 A AU1889588 A AU 1889588A AU 1889588 A AU1889588 A AU 1889588A
Authority
AU
Australia
Prior art keywords
tumours
agent
high affinity
diagnosis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU18895/88A
Other versions
AU623080B2 (en
Inventor
Hannu Aronen
Sirkka-Liisa Karonen
Jan Lindgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU1889588A publication Critical patent/AU1889588A/en
Application granted granted Critical
Publication of AU623080B2 publication Critical patent/AU623080B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Motorcycle And Bicycle Frame (AREA)

Abstract

The vehicle consists of tissue plasminogen activator or an essential part thereof and is used both for the diagnosis and therapy of malignant tumours.
AU18895/88A 1987-07-08 1988-07-08 Use of an agent with a high affinity for tumours Ceased AU623080B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3722522 1987-07-08
DE19873722522 DE3722522A1 (en) 1987-07-08 1987-07-08 USE OF A VEHICLE WITH HIGH AFFINITY TO TUMORS

Publications (2)

Publication Number Publication Date
AU1889588A true AU1889588A (en) 1989-01-12
AU623080B2 AU623080B2 (en) 1992-05-07

Family

ID=6331118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18895/88A Ceased AU623080B2 (en) 1987-07-08 1988-07-08 Use of an agent with a high affinity for tumours

Country Status (13)

Country Link
EP (1) EP0298436B1 (en)
JP (1) JPH01125331A (en)
KR (1) KR890001508A (en)
AT (1) ATE81473T1 (en)
AU (1) AU623080B2 (en)
DE (2) DE3722522A1 (en)
DK (1) DK167561B1 (en)
ES (1) ES2046244T3 (en)
FI (1) FI883177A (en)
GR (1) GR3006404T3 (en)
NO (1) NO883040L (en)
NZ (1) NZ225350A (en)
ZA (1) ZA884870B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Also Published As

Publication number Publication date
EP0298436B1 (en) 1992-10-14
JPH01125331A (en) 1989-05-17
DK167561B1 (en) 1993-11-22
NZ225350A (en) 1991-07-26
EP0298436A3 (en) 1990-01-17
DK377588A (en) 1989-01-09
DE3875290D1 (en) 1992-11-19
ES2046244T3 (en) 1994-02-01
FI883177A (en) 1989-01-09
ATE81473T1 (en) 1992-10-15
DK377588D0 (en) 1988-07-07
DE3722522A1 (en) 1989-01-19
KR890001508A (en) 1989-03-27
FI883177A0 (en) 1988-07-04
ZA884870B (en) 1989-04-26
GR3006404T3 (en) 1993-06-21
NO883040L (en) 1989-01-09
NO883040D0 (en) 1988-07-07
AU623080B2 (en) 1992-05-07
EP0298436A2 (en) 1989-01-11

Similar Documents

Publication Publication Date Title
AU2019788A (en) Bone cement for sustained release of substances
ES8203599A1 (en) Therapeutic device
ES2130217T3 (en) USE OF TILOXAPOL AS A DISPERSANT AND STABILIZER OF NANOPARTICLES.
AU2883689A (en) The use of moclobemide to treat or prevent cognitive disorders
AU6772387A (en) Treatment of thrombosis with fibrinolytic agents and prostacyclines
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
EP0328957A3 (en) Mixture of a thrombolytically acting and an antithrombolytically acting substance
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
AU6823390A (en) An agent for improving the recovery of annexins
AU1889588A (en) Use of an agent with a high affinity for tumours
GB8819607D0 (en) Novel combination
AU558587B2 (en) Antiinflammatory composition of inositol and piroxicam
EP0350738A3 (en) (s)-emopamil for use in the treatment of migraine
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
AU7999687A (en) Active compounds for preventing tumor metastases
GR3000751T3 (en) Tpa-containing medical composition and use thereof
AU2525488A (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy
AU2131792A (en) Novel human tissue-type plasminogen activator variant
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
AU7719491A (en) Therapeutic compound
AU7647187A (en) Tourniquet for parts of the body
AU7117891A (en) Therapeutic agent for diabetic gangrene
JPS5477354A (en) Disc of regenerative instrument and assemblied body of coupler of drive portion
AU3430189A (en) Compounds for diagnosis and/or therapy of tumours